BRO Q1 2026: Organic Flat at 0.0% Resolves NO, Margin and $250M Buyback Hold the Floor

Brown & Brown reported Q1 2026 Organic Revenue growth of 0.0% — flat against Q1 2025 and well below the 3.0% market threshold. The binary market resolves NO at a Brier of 0.270 against the ensemble's 0.52 prior. At the same time, Adjusted EBITDAC margin expanded 40 bps to 38.5%, Adjusted EPS grew 7.8% to $1.39, operating cash flow rose 23% to $262M, and management deployed $250M in share repurchases — half of the FY2026 $500M market threshold in a single quarter. The baseline thesis published three days earlier classified BRO price-below-value MEDIUM at $65.90; that classification holds, but the asymmetry has narrowed.

The Numbers

What Changed: Signal Movements

Five signal shifts across three lenses:

• Gravy Gauge — REVENUE_DURABILITY: CONDITIONAL → CONDITIONAL with trajectory tilting toward FRAGILE. Q1 was supposed to be the easiest quarter — post-Q4's -2.8% trough, before tighter casualty rate comps in H2. The 0.0% print suggests either H1 stays at-or-near zero or the recovery is materially back-loaded.
• Stress Scanner — FUNDING_FRAGILITY: ROBUST → ROBUST (reinforced). $262M Q1 CFO + $250M buybacks + $1.45B FY25 baseline + $1.5B authorization remaining demonstrate unambiguous financial flexibility through the cyclical trough.
• Stress Scanner — STRESS_RESILIENCE: MODERATE → MODERATE leaning STRONG. 40 bps margin expansion in Q1 despite organic weakness shows the cumulative-headwind framing was somewhat overstated. The investment income reversal materialized as guided ($21M vs $19M PY).
• Myth Meter — NARRATIVE_REALITY_GAP: SIGNIFICANT_GAP narrowing toward the MINOR_GAP boundary. The bear narrative on deceleration was partially validated. The bull narrative on margin and capital strength continues to disconnect from a "broken business" interpretation. Net: the gap is real but smaller.
• Moat Mapper — GOVERNANCE_ALIGNMENT: STRONG → STRONG (reinforced). $250M Q1 buyback at depressed prices plus dividend continuity at $0.165 (annual increases historically announced on the Q3 call) signals continuing family-aligned capital discipline.

Forecast Markets: One Resolved, Six Active

The Q1 organic resolution is the data point worth dwelling on. The 0.52 prior probability sat almost exactly at coin-flip and assumed a recovery path from Q4 2025's -2.8% trough into modest positive territory. The actual 0.0% print did not just miss the threshold — it landed below the prior FY25 baseline of 2.8%. Three drivers: continued CAT property soft cycle (-15-30% rates), $10M of Howden Litigation- Related Impact carved out of organic (cumulative roughly $33M), and a tough comp against Q1 2025's 6.5% on a softer base.

What's Still Active

• Q2 2026 organic recovery (new trigger bro-t7): Q2 organic above 3% preserves the cyclical framing; Q2 below 2% marks two consecutive misses and shifts REVENUE_DURABILITY toward FRAGILE. Resolves early August.
• Howden cumulative trajectory: $33M cumulative against $50M threshold; at the Q1 incremental pace of $10M, cumulative reaches $63M by Q4 — above the bar.
• Buyback cadence (new trigger bro-t8): Sustained $100M+/quarter through 2026 confirms management conviction; deceleration below $50M/quarter would suggest a pivot to balance sheet management or M&A.
• Accession segment read: Q1 segment-level Accession revenue not disclosed in the press release. The 10-Q (filed same day) and Q1 conference call transcript are the next inputs for the H1 miss market.
• FY26 guide reaffirm or revise: Pre-earnings, management framed FY26 as "modest improvement over 2.8%." Post-Q1, that is mathematically harder. The Q1 call commentary on guide is decision-relevant for the FY26 organic above 4% market.

The Bigger Picture

Classification stays price-below-value at $65.90 with confidence MEDIUM, but conviction has been reduced. The pre-earnings load-bearing variable was Q1 cadence — a binary that is now resolved bearish. The post-earnings load-bearing variables are different: Q2 organic, conference-call commentary on FY26 guide and Accession synergy realization, and the cumulative Howden trajectory against the $50M market threshold. The durability ensemble (margin floor at 84% pre-Q1, dividend continuity at 96%, Howden $50M+ at 25%) remains intact and is reinforced on margin and capital. The cyclical-organic ensemble has weakened — the FY26 organic above 4% market should compress from 32% toward 15-25%.

At $65.90 (down 44% from prior peak), BRO trades at roughly 18-19x trailing earnings against Marsh & McLennan and Aon at 22-25x. Q1 validates that the multiple compression captures real cyclical pressure. But the magnitude of margin and capital strength — Q1 38.5% adjusted EBITDAC, $262M operating cash flow, $250M of buyback execution — continues to disconnect from a permanent broken-business multiple. The risk of a tail-risk "broken business" outcome has receded; the risk of a value-trap outcome (fair price, slow recovery) has risen. Re-rating now requires multiple quarters of evidence rather than a single cadence beat — a more classic value setup than the tactical mispricing trade priced into the pre-earnings ensemble.